Treat to Target in Axial Spondyloarthritis Pros, Cons, and Future Directions

被引：7

作者：

Liew, Jean W. ^{[1
]}

Dubreuil, Maureen ^{[2
]}

机构：

[1] Univ Washington, Dept Med, Div Rheumatol, 1959 Northeast Pacific St,BB561, Seattle, WA 98195 USA

[2] Boston Univ, Sch Med, Sect Rheumatol, 650 Albany St,X201, Boston, MA 02119 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2020年 / 46卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Treat to target; Disease activity; Axial spondyloarthritis; Ankylosing spondylitis; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SPINAL RADIOGRAPHIC PROGRESSION; ANKYLOSING-SPONDYLITIS; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; PHYSICAL FUNCTION; AMERICAN-COLLEGE; TIGHT CONTROL; MRI INFLAMMATION;

D O I：

10.1016/j.rdc.2020.01.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treat to target describes a management paradigm that involves choosing a clinically relevant target, assessment with validated measures at a prespecified frequency, and a change in therapy if the target is not met. Although guidelines recommend treating to target in axial spondyloarthritis (axSpA), ideal methods to reach this target remain controversial. This review focuses on background for a treat-to-target strategy in axSpA. Potential targets of treatment, association of targets with outcomes, evidence of treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed. Treat-to-target trials and the research agenda for studies in axSpA are discussed.

引用

页码：343 / +

页数：15

共 50 条

[31] Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies
Akkoc, Nurullah
Can, Gercek
D'Angelo, Salvatore
Padula, Angela
Olivieri, Ignazio
CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
[32] Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target
Bolt, Janne W.
Aalbers, Caroline J.
Walet, Laura
van Mens, Leonieke J. J.
van Denderen, Christiaan
van der Horst-Bruinsma, Irene
van Baarsen, Lisa G. M.
Landewe, Robert
van de Sande, Marleen G. H.
RHEUMATOLOGY, 2024, 63 (01) : 34 - 40
[33] Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study
Smits, Marius L.
Webers, Casper
van Dooren, Mirte
Mahler, Elien A. M.
Vriezekolk, Johanna E.
van Tubergen, Astrid
RHEUMATOLOGY INTERNATIONAL, 2025, 45 (02)
[34] Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis
Schoels, M. M.
Braun, J.
Dougados, M.
Emery, P.
Fitzgerald, O.
Kavanaugh, A.
Kvien, T. K.
Landewe, R.
Luger, T.
Mease, P.
Olivieri, I.
Reveille, J.
Ritchlin, C.
Rudwaleit, M.
Sieper, J.
Smolen, J. S.
de Wit, M.
van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 238 - 242
[35] Treating to target in axial spondyloarthritis: defining the target and the arrow
Wendling, Daniel
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (06) : 691 - 693
[36] Active Radiofrequency Metamaterial Structures - Pros, Cons and Future Trends
Hrabar, Silvio
9TH INTERNATIONAL CONGRESS ON ADVANCED ELECTROMAGNETIC MATERIALS IN MICROWAVES AND OPTICS (METAMATERIALS 2015), 2015, : 418 - 420
[37] Hybrid nuclear/CT cardiac imaging: Pros cons and the future
Brodov, Yafim
Chouraqui, Pierre
Goitein, Orly
JOURNAL OF NUCLEAR CARDIOLOGY, 2023, 30 (06) : 2361 - 2364
[38] Hybrid nuclear/CT cardiac imaging: Pros cons and the future
Yafim Brodov
Pierre Chouraqui
Orly Goitein
Journal of Nuclear Cardiology, 2023, 30 : 2361 - 2364
[39] Treat to Target in Spondyloarthritis: The Time has Come
El Miedany, Yasser
CURRENT RHEUMATOLOGY REVIEWS, 2014, 10 (02) : 87 - 93
[40] Difficult-to-Treat Axial Spondyloarthritis: A New Challenge
Wendling, Daniel
DRUGS, 2024, : 1501 - 1508

← 1 2 3 4 5 →